DRKS00018787已完成不适用
Patient preferences for treatment of Hidradenitis suppurativa
niversitätsmedizin Göttingen0 个研究点目标入组 223 人开始时间: 2019年9月6日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 223
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •Dated and signed consent form
- •- Patients with physician-diagnosed Hidradenitis suppurativa, irrespective of disease severity or current or former therapy
- •- Age = 18 Jahre
- •- Ability to understand discrete choice experiments
排除标准
- •Any member of the study team who is directly or indirectly involved in the study
研究者
相似试验
已完成
不适用
Treatment of Hidradenitis Suppurativa with a blue light (415 nm) and red light(633 nm) combination PDTacne inversa10014982hidradenitis suppurativaNL-OMON31302Catharina-ziekenhuis11
已完成
不适用
Treatment of Hidradenitis Suppurativa With Eth 755nm Alexandrite LaserHidradenitis SuppurativaNCT03054155Wayne State University30
终止
不适用
Safety and Treatment of Cryoinsufflation in Treatment of Hidradenitis SuppurativaHidradenitis SuppurativaNCT05830149Henry Ford Health System1
已完成
2 期
A Study of Oral Upadacitinib Tablet Compared to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa to Assess Change in Disease SymptomsHidradenitis Suppurativa (HS)NCT04430855AbbVie68
已完成
2 期
A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa.Hidradenitis SuppurativaNCT03248531UCB Biopharma SRL90